This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: John Knapp: Innovator in Cystic Fibrosis Research
Introduction
John Knapp is a notable inventor based in Davis, CA (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the treatment of cystic fibrosis. His work focuses on developing compounds that enhance the function of mutant cystic fibrosis transmembrane conductance regulator protein (mutant-CFTR).
Latest Patents
John Knapp holds a patent for "Cyanoquinoline compounds having activity in correcting mutant-CFTR processing and increasing ion transport and uses thereof." This patent outlines pharmaceutical compositions and methods aimed at increasing the activity of mutant-CFTR. These innovations are crucial for studying and treating disorders associated with mutant-CFTR, including cystic fibrosis. The compositions may include cyanoquinoline-containing compounds or their analogs and derivatives.
Career Highlights
John Knapp is affiliated with the University of California, where he conducts his research. His work has led to advancements in understanding and treating cystic fibrosis, a genetic disorder that affects the lungs and digestive system. His dedication to this field has positioned him as a key figure in pharmaceutical research.
Collaborations
Some of his notable coworkers include Alan S Verkman and Puay-Wah Phuan. Their collaborative efforts have contributed to the development of innovative solutions for cystic fibrosis treatment.
Conclusion
John Knapp's contributions to cystic fibrosis research through his patented innovations highlight the importance of scientific inquiry in addressing complex health issues. His work continues to pave the way for advancements in pharmaceutical treatments.